Benlysta (belimumab) is a biologic medication approved to treat active SLE and lupus nephritis (LN) in people aged 5 and older. It works by blocking a protein called BLyS, which helps certain immune cells (B cells) survive. By reducing these B cells, Benlysta helps lower lupus disease activity. When given as an IV infusion Show Full Answer
Benlysta (belimumab) is a biologic medication approved to treat active SLE and lupus nephritis (LN) in people aged 5 and older. It works by blocking a protein called BLyS, which helps certain immune cells (B cells) survive. By reducing these B cells, Benlysta helps lower lupus disease activity. When given as an IV infusion, here's what to expect:
- Infusions are administered in a medical setting like an outpatient treatment center
- Each infusion takes about one hour
- The first three doses are given every two weeks
- After that, infusions are given once every four weeks
- A healthcare provider may give pre-medications to help prevent allergic or infusion reactions
- You'll be monitored throughout, which also gives you a chance to ask questions
Being in a medical setting during infusions is actually a plus — it means any reactions can be caught and managed quickly. It's important to know that Benlysta doesn't work overnight. Some immune system changes can be seen as early as 8–12 weeks, but full benefits may take several months. Staying consistent with your dosing schedule is really important — missing doses can trigger a flare.
Some key risks to be aware of include:
- Serious infections
- Allergic reactions
- Depression or suicidal thoughts — contact your doctor right away if you notice mood changes
Always keep your care team informed about how you're feeling between doses.
October 3
Hi, this is just a check-in, based on a phrase you mentioned. If you — or anyone else who sees this — is thinking about self-harm, we want to say that you are an important part of this community. No part of this is easy, but there is support that can help.
Read more >
Join
Your Privacy Choices
